Isosorbide-5-Mononitrate
Products in Health Canada’s databases that list Isosorbide-5-Mononitrate as a medicinal or active ingredient. Its salts and forms that the databases name on their own have their own pages.
- Drug products
- 10
- 6 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 18
- Products in all
- 10
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| APO-ISMN (60 MG) | 02272830 | Marketed | Apotex Inc. | |
| PMS-ISMN (60 MG) | 02301288 | Marketed | Pharmascience Inc. | |
| PRO-ISMN - 60 (60 MG) | 02311321 | Marketed | Pro Doc Limitee | |
| PRZ-ISMN (60 MG) | 02562561 | Marketed | Pharmaris Canada Inc. | |
| IMDUR (60 MG) | 02126559 | Dormant | Juno Pharmaceuticals Corp. | |
| RIVA-ISMN (60 MG) | 02570742 | Approved | Laboratoire Riva Inc. | |
| DOM-ISMN (60 MG) | 02307758 | Cancelled Pre Market | Dominion Pharmacal | |
| ISMN (60 MG) | 02446073 | Cancelled Post Market | Sivem Pharmaceuticals Ulc | |
| ISMO TAB 20MG (20 MG) | 02058472 | Cancelled Post Market | Wyeth-Ayerst Canada Inc. | |
| PHL-ISMN (60 MG) | 02307731 | Cancelled Pre Market | Pharmel Inc. |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- RIVA-ISMNAugust 10, 2026 · NOC 38069
- PRZ-ISMNOctober 31, 2025 · NOC 36303
- PMS-ISMNSeptember 12, 2024 · NOC 33997
- IMDURJuly 27, 2023 · NOC 31316
- IMDUROctober 5, 2021 · NOC 26759
- IMDURSeptember 14, 2020 · NOC 24218
- IMDURDecember 7, 2018 · NOC 21613
- IMDURAugust 3, 2018 · NOC 21181
- ISMNOctober 5, 2015 · NOC 17350
- ISMNApril 20, 2010 · NOC 11262
- ZYM-ISMNSeptember 29, 2008 · NOC 9803
- PRO-ISMN - 60June 13, 2008 · NOC 9619
- PHL-ISMNApril 23, 2008 · NOC 9508
- DOM-ISMNApril 23, 2008 · NOC 9509
- PMS-ISMNOctober 25, 2007 · NOC 9137
- APO-ISMNNovember 7, 2005 · NOC 7594
- IMDURApril 20, 2000 · NOC 1226
- IMDURSeptember 8, 1994 · NOC 5678